Remember the Babies: The Need for Off-Label Pediatric Use of COVID-19 Vaccines
The CDC is failing parents by preventing off-label use of our existing COVID-19 vaccines in the under-five set.

The NIH, which funded much of Moderna’s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this research.

The discrepancy between past booster messaging and the current, broad recommendation has spawned public health communications problems.

COVID-19 vaccine hesitancy is further exacerbated by waves of misinformation promulgated on social media.

State litigation and legislation has created a landscape of uncertainty surrounding the legal status of the federal COVID-19 vaccine mandate.

Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.

The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.

The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.

COVID-19 vaccine mandates could offer a potential foothold to increase vaccination for other communicable diseases, such as the influenza virus.
